With so many supplements on the market, how do you know which ones work? Understanding the role of bioavailability can help you choose the right products to support your health.
A growing body of literature suggests that CBD is a well-tolerated adjunct therapy that will aid recovery and make patients more comfortable during and after chemotherapy.
For those who are interested in integrating cannabinoids in their treatment plans, understanding these differences between CBD and THC is essential to optimize therapeutic benefits while minimizing risk.
Emerging research suggests that curcumin can enhance weight loss even in patients who have previously struggled with conventional weight loss efforts due to metabolic disorders.
A recent flurry of promising investigations on berberine shows that this unique chemical can successfully treat insulin resistance as well or better than conventional treatment methods.
The benefits of curcumin stem primarily from its anti-inflammatory and antioxidant activities, but it also has antimicrobial and protein regulatory properties that further expand its potential benefits as a therapy.
Concerns about Alzheimer’s disease risk have sparked decades of research on prevention methods, including strategies that focus on food and nutritional supplements as potential preventive measures.
Thanks to curcumin’s impact on inflammation, immune cells, and the body’s response to stress, patients may have the ability to prevent or slow the progression of neurodegenerative conditions such as Alzheimer’s and Parkinson’s.
Preliminary studies suggest that supplements derived from phenolic compounds, such as quercetin and curcumin, and other antioxidants may serve as effective therapeutics for reducing hangover symptoms.
In light of growing evidence, researchers are now considering the endocannabinoid system as a possible target for future therapeutics that treat social anxiety in patients with autism.